(VIANEWS) – Churchill Downs (CHDN), Entergy Louisiana, LLC First Mortgage Bonds, 5.875% (ELA), Ulta Beauty (ULTA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Churchill Downs (CHDN)
15.8% sales growth and 48.97% return on equity
Churchill Downs Incorporated operates as a racing, online wagering, and gaming entertainment company in the United States. It operates through three segments: Live and Historical Racing, TwinSpires, and Gaming. As of December 31, 2021, the company owned and operated three pari-mutuel gaming entertainment venues with approximately 3,050 historical racing machines (HRMs) in Kentucky; TwinSpires, an online wagering platform for horse racing, sports, and iGaming; nine retail sportsbooks; and casino gaming in eight states with approximately 11,000 slot machines and video lottery terminals, and 200 table games. It also offers streaming video of live horse races, replays, and an assortment of racing and handicapping information; and provides the Bloodstock Research Information Services platform for horse racing statistical data. In addition, the company manufactures and operates pari-mutuel wagering systems for racetracks, off-track betting facilities, and other pari-mutuel wagering businesses. Churchill Downs Incorporated was founded in 1875 and is headquartered in Louisville, Kentucky.
Earnings Per Share
As for profitability, Churchill Downs has a trailing twelve months EPS of $4.69.
PE Ratio
Churchill Downs has a trailing twelve months price to earnings ratio of 23.46. Meaning, the purchaser of the share is investing $23.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.97%.
Moving Average
Churchill Downs’s worth is under its 50-day moving average of $119.04 and way under its 200-day moving average of $125.99.
2. Entergy Louisiana, LLC First Mortgage Bonds, 5.875% (ELA)
13.2% sales growth and 32.75% return on equity
Envela Corporation, together with its subsidiaries, primarily buys and sells jewelry and bullion products to individual consumers, dealers, Fortune 500 companies, municipalities, school districts, and other organizations in the United States. It offers jewelry and fine-watch products, including bridal jewelry, fashion jewelry, custom-made jewelry, diamonds, and other gemstones, as well as watches and jewelry components. The company also buys and sells various forms of gold, silver, platinum, and palladium products, including United States and other government coins, private mint medallions, art bars, and trade unit bars; and numismatic items, such as rare coins, currency, medals, tokens, and other collectibles, as well as provides jewelry and watches repair services. In addition, it offers end-of-life electronics recycling services; disposal transportation and product tracking services; IT-asset disposition services, including compliance and data sanitization services; and services to companies in the areas of software upgrades, and hardware or networking capabilities, as well as moving to cloud services. As of December 31, 2021, Envela Corporation marketed its products and services through six retail locations under the Dallas Gold & Silver Exchange name; and one retail location under the Charleston Gold & Diamond Exchange name, as well as through cgdeinc.com, dgse.com, echoenvironmental.com, ITADUSA.com, availrecovery.com, and teladvance.com e-commerce sites. The company was formerly known as DGSE Companies, Inc. and changed its name to Envela Corporation in December 2019. Envela Corporation was incorporated in 1965 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months EPS of $0.49.
PE Ratio
Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months price to earnings ratio of 9.02. Meaning, the purchaser of the share is investing $9.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.75%.
3. Ulta Beauty (ULTA)
9.3% sales growth and 66.08% return on equity
Ulta Beauty, Inc. operate specialty retail stores selling cosmetics, fragrance, haircare and skincare products, and related accessories and services in the United States. It offers broad assortment of branded and private label beauty products including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools; and salon services, including hair, skin, makeup, and brow services, as well as nail services. The company's private label products comprises Ulta Beauty Collection branded cosmetics, skincare, and bath products, as well as Ulta Beauty branded products; and the Ulta Beauty branded gifts. It also distributes its products through its stores, website, and mobile applications. The company was incorporated in 1990 and is based in Bolingbrook, Illinois.
Earnings Per Share
As for profitability, Ulta Beauty has a trailing twelve months EPS of $25.19.
PE Ratio
Ulta Beauty has a trailing twelve months price to earnings ratio of 15.16. Meaning, the purchaser of the share is investing $15.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 66.08%.
Moving Average
Ulta Beauty’s worth is below its 50-day moving average of $416.06 and way below its 200-day moving average of $475.18.
Yearly Top and Bottom Value
Ulta Beauty’s stock is valued at $381.86 at 06:22 EST, way under its 52-week high of $556.60 and above its 52-week low of $373.80.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 10.73B for the twelve trailing months.
4. Primoris Services Corporation (PRIM)
8.5% sales growth and 11.45% return on equity
Primoris Services Corporation, a specialty contractor company, provides a range of construction, fabrication, maintenance, replacement, and engineering services in the United States and Canada. It operates through three segments: Utilities, Energy/Renewables, and Pipeline Services. The Utilities segment offers installation and maintenance services for new and existing natural gas distribution systems, electric utility distribution and transmission systems, and communications systems. The Energy/Renewables segment provides a range of services, including engineering, procurement, and construction, as well as retrofits, highway and bridge construction, demolition, site work, soil stabilization, mass excavation, flood control, upgrades, repairs, outages, and maintenance services to renewable energy and energy storage, renewable fuels, petroleum, refining, and petrochemical industries, as well as state departments of transportation. The Pipeline Services segment offers a range of services comprising pipeline construction, maintenance, facility, and integrity services; installation of compressor and pump stations; and metering facilities for entities in the petroleum and petrochemical industries, as well as gas, water, and sewer utilities. The company was founded in 1960 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Primoris Services Corporation has a trailing twelve months EPS of $2.32.
PE Ratio
Primoris Services Corporation has a trailing twelve months price to earnings ratio of 14.11. Meaning, the purchaser of the share is investing $14.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.45%.
5. Stantec (STN)
7% sales growth and 13.54% return on equity
Stantec Inc. provides e professional services in the areas of infrastructure and facilities to the public and private sectors clients in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. It also offers planning and design consulting services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. In addition, it provides transportation planning and engineering services; project delivery consultancy services for mining, resources, and industrial infrastructure projects; and paleontological and archaeological services for the rail, transportation, water, and power and energy sectors. Further, the company offers environmental and cultural resource compliance services, as well as serves science and technology, commercial workplace, higher education, residential, and hospitality markets. Additionally, it is involved in the design, development, and delivery of sustainable projects; and design, construction administration, commissioning, maintenance, decommissioning, and remediation activities. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Stantec has a trailing twelve months EPS of $1.95.
PE Ratio
Stantec has a trailing twelve months price to earnings ratio of 33.68. Meaning, the purchaser of the share is investing $33.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.54%.
6. Globus Medical (GMED)
5.8% sales growth and 11.09% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $2.05.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 26.02. Meaning, the purchaser of the share is investing $26.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.09%.
Sales Growth
Globus Medical’s sales growth is 5.8% for the present quarter and 5.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 1.1B for the twelve trailing months.
Previous days news about Globus Medical(GMED)
- Globus medical (gmed) gains from nuvasive buyout, innovation. According to Zacks on Friday, 13 October, "In the second quarter of 2023, Globus Medical launched three new products, REFLECT, MARVEL and Ossifuse.", "Going by our model, in 2023, Globus Medical is expected to incur a 9.9% rise in the cost of goods sold from the previous year."
